cefbuperazone has been researched along with Escherichia coli Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amemiya, K; Asano, T; Kameyama, J; Kaneda, N; Murakami, N; Senda, H; Tsukamoto, M | 1 |
| Hirai, Y; Imamura, K; Kumasaka, Y; Nakahata, H; Senda, H; Suzuki, I; Takebe, K | 1 |
2 other study(ies) available for cefbuperazone and Escherichia coli Infections
| Article | Year |
|---|---|
Experimental studies on the pharmacokinetics and therapeutic effect of cefbuperazone in biliary infection.
Topics: Animals; Cephamycins; Escherichia coli Infections; Female; Gallbladder Diseases; Injections, Intramuscular; Microbial Sensitivity Tests; Rabbits; Tissue Distribution | 1989 |
[In vivo antibacterial activity of cefbuperazone. Synergy of cefbuperazone for bactericidal effect with human polymorphonuclear leukocytes].
Topics: Animals; Blood Bactericidal Activity; Cefmetazole; Cefoperazone; Cefotetan; Cephamycins; Escherichia coli; Escherichia coli Infections; Male; Mice; Mice, Inbred ICR; Moxalactam; Neutrophils | 1986 |